Antineutrophil cytoplasmic antibody-associated vasculitis: autoinflammation, autodestruction and autoimmunity - key to new therapies

Trends in Immunology

Volumn 29, Issue 12, 2008, Pages 587-588

  Lamprecht, Peter ^a   Gross, Wolfgang L ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DNA; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROCASPASE 3; PROTEIN TYROSINE PHOSPHATASE; RETINOID X RECEPTOR BETA; RING FINGER PROTEIN; RNA; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; URATE;

ANCA ASSOCIATED VASCULITIS; APOPTOSIS; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; B LYMPHOCYTE; BERYLLIOSIS; CELL MATURATION; CELL SURVIVAL; DEGRANULATION; DENDRITIC CELL; DNA POLYMORPHISM; ENDOTHELIUM LESION; ENZYME ACTIVITY; GENETIC PREDISPOSITION; HAPLOTYPE; HEREDITY; HISTOLOGY; IMMUNOTHERAPY; LETTER; LEUKOCYTE ACTIVATION; MACROPHAGE; MICROSCOPIC POLYANGIITIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; T LYMPHOCYTE; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; INFLAMMATION; VASCULITIS;

EID: 56549090920     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.09.003     Document Type: Letter

References (12)

1. Bosch X., et al. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?. Trends Immunol. 29 (2008) 280-289
2. Lamprecht P., et al. T-cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener's granulomatosis. Arthritis Rheum. 56 (2007) 1725-1727
3. Fanciulli M., et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet. 39 (2007) 721-723
4. Jagiello P., et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum. 52 (2005) 4039-4043
5. Heckmann M., et al. The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterized by tagSNP genotyping. Ann. Rheum. Dis. 67 (2008) 972-979
6. Lombardi G., et al. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J. Immunol. 166 (2001) 3549-3555
7. Wieczorek S., et al. Functionally relevant variations of the interleukin-10 gene are associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis. Arthritis Rheum. 58 (2008) 1839-1848
8. Meylan E., et al. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
9. Gregersen P.K. Modern genetics, ancient defenses, and potential therapies. N. Engl. J. Med. 356 (2007) 1263-1266
10. Novick D., et al. Proteinase 3 is an IL-32 binding protein. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3316-3321
11. Pederzoli M., et al. Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils. J. Immunol. 174 (2005) 6381-6390
12. Csernok E., et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 107 (2006) 4440-4448